The risk model constructed based on SLC41A3, SEC61A1, LRP4, PPM1G, and HSP90AA1 is expected to enable the prognosis of patients with HCC and significantly correlated with the levels of infiltrating immune cells in HCC. This evidence concerns the gene HSP90AA1 and hepatocellular carcinoma.